ReP USP - Resultado da busca

Artigo de periodico
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster (2024)
Machado, Rafael Rahal Guaragna ; Candido, Erika Donizette de Oliveira ; Aguiar, Andressa Simões ; Chalup, Vanessa Nascimento ; Sanches, Patricia Romão ; Dorlass, Erick Gustavo ; Amgarten, Deyvid Emanuel ; Pinho, João Renato Rebello ; Oliveira, Danielle Bruna Leal de
Fonte: Vaccines. Unidades: FM, ICB, BIOINFORMÁTICA
Assuntos: MICROBIOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, ANTICORPOS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, v. 12, n. 2, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12020144. Acesso em: 25 set. 2024.
APA
Machado, R. R. G., Candido, E. D. de O., Aguiar, A. S., Chalup, V. N., Sanches, P. R., Dorlass, E. G., et al. (2024). Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, 12( 2). doi:10.3390/vaccines12020144
NLM
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12020144
Vancouver
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12020144
Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 25 set. 2024.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Serological responses of guinea pigs and heifers to eight different BoAHV-1 vaccine formulations (2024)
Camargo, Luana; Franklin, Yasmin Vieira; Silva, Gustavo Feliciano Resende da; Santos, Janaína Ferreira ; Parreño, Viviana Gladys ; Wigdorovitz, Andrés; Gomes, Viviani
Fonte: Vaccines. Unidade: FMVZ
Assuntos: BOVINOS, ALPHAHERPESVIRINAE, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Luana et al. Serological responses of guinea pigs and heifers to eight different BoAHV-1 vaccine formulations. Vaccines, v. 12, n. 6, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12060615. Acesso em: 25 set. 2024.
APA
Camargo, L., Franklin, Y. V., Silva, G. F. R. da, Santos, J. F., Parreño, V. G., Wigdorovitz, A., & Gomes, V. (2024). Serological responses of guinea pigs and heifers to eight different BoAHV-1 vaccine formulations. Vaccines, 12( 6), 1-13. doi:10.3390/vaccines12060615
NLM
Camargo L, Franklin YV, Silva GFR da, Santos JF, Parreño VG, Wigdorovitz A, Gomes V. Serological responses of guinea pigs and heifers to eight different BoAHV-1 vaccine formulations [Internet]. Vaccines. 2024 ; 12( 6): 1-13.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12060615
Vancouver
Camargo L, Franklin YV, Silva GFR da, Santos JF, Parreño VG, Wigdorovitz A, Gomes V. Serological responses of guinea pigs and heifers to eight different BoAHV-1 vaccine formulations [Internet]. Vaccines. 2024 ; 12( 6): 1-13.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines12060615
Artigo de periodico
Using an aluminum hydroxide–chitosan matrix increased the vaccine potential and immune response of mice against multi-drug-resistant acinetobacter baumannii (2023)
Deusdará, Túllio T. ; Félix, Mellaine K. C.; Brito, Helio de S. ; Cangussu, Edson W. S. ; Moura, Wellington de S. ; Albuquerque, Benedito; Silva, Marcos G.; Santos, Gil R. dos ; Morais, Paula B. de ; Silva, Elizangela F. da; Chaves, Yuri O.; Mariúba, Luis André M. ; Nogueira, Paulo A.; Astolfi-Filho, Spartaco ; Assunção, Enedina N. ; Epiphanio, Sabrina ; Brandi, Igor V. ; Kelvinson F. Viana ; Oliveira, Eugenio E. ; Cangussu, Alex Sander R. ; Marinho, Claudio Romero Farias
Fonte: Vaccines. Unidades: FCF, ICB
Assuntos: PARASITOLOGIA, BACTÉRIAS AERÓBICAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, ADJUVANTES IMUNOLÓGICOS, VACINAS, CAMUNDONGOS, IMUNOGLOBULINAS, SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEUSDARÁ, Túllio T. et al. Using an aluminum hydroxide–chitosan matrix increased the vaccine potential and immune response of mice against multi-drug-resistant acinetobacter baumannii. Vaccines, v. 11, n. 3, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11030669. Acesso em: 25 set. 2024.
APA
Deusdará, T. T., Félix, M. K. C., Brito, H. de S., Cangussu, E. W. S., Moura, W. de S., Albuquerque, B., et al. (2023). Using an aluminum hydroxide–chitosan matrix increased the vaccine potential and immune response of mice against multi-drug-resistant acinetobacter baumannii. Vaccines, 11( 3), 1-15. doi:10.3390/vaccines11030669
NLM
Deusdará TT, Félix MKC, Brito H de S, Cangussu EWS, Moura W de S, Albuquerque B, Silva MG, Santos GR dos, Morais PB de, Silva EF da, Chaves YO, Mariúba LAM, Nogueira PA, Astolfi-Filho S, Assunção EN, Epiphanio S, Brandi IV, Kelvinson F. Viana, Oliveira EE, Cangussu ASR, Marinho CRF. Using an aluminum hydroxide–chitosan matrix increased the vaccine potential and immune response of mice against multi-drug-resistant acinetobacter baumannii [Internet]. Vaccines. 2023 ; 11( 3): 1-15.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11030669
Vancouver
Deusdará TT, Félix MKC, Brito H de S, Cangussu EWS, Moura W de S, Albuquerque B, Silva MG, Santos GR dos, Morais PB de, Silva EF da, Chaves YO, Mariúba LAM, Nogueira PA, Astolfi-Filho S, Assunção EN, Epiphanio S, Brandi IV, Kelvinson F. Viana, Oliveira EE, Cangussu ASR, Marinho CRF. Using an aluminum hydroxide–chitosan matrix increased the vaccine potential and immune response of mice against multi-drug-resistant acinetobacter baumannii [Internet]. Vaccines. 2023 ; 11( 3): 1-15.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11030669
Artigo de periodico
Sph2(176–191) and Sph2(446–459): identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), naturally recognized by patients infected by pathogenic Leptospires (2023)
Ataides, Laura Sant’Anna ; Maia, Fernanda de Moraes ; Conte, Fernando Paiva ; Isaac, Lourdes ; Barbosa, Angela Silva ; Lima-Junior, Josué da Costa ; Avelar, Kátia Eliane Santos ; Silva, Rodrigo Nunes Rodrigues da
Fonte: Vaccines. Unidade: ICB
Assuntos: IMUNOLOGIA, EPITOPOS, LEPTOSPIROSE, MEMBRANAS CELULARES, CÉLULAS EUCARIÓTICAS, LINFÓCITOS B
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ATAIDES, Laura Sant’Anna et al. Sph2(176–191) and Sph2(446–459): identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), naturally recognized by patients infected by pathogenic Leptospires. Vaccines, v. 11, n. 2, p. 1-19, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11020359. Acesso em: 25 set. 2024.
APA
Ataides, L. S. ’A., Maia, F. de M., Conte, F. P., Isaac, L., Barbosa, A. S., Lima-Junior, J. da C., et al. (2023). Sph2(176–191) and Sph2(446–459): identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), naturally recognized by patients infected by pathogenic Leptospires. Vaccines, 11( 2), 1-19. doi:10.3390/vaccines11020359
NLM
Ataides LS’A, Maia F de M, Conte FP, Isaac L, Barbosa AS, Lima-Junior J da C, Avelar KES, Silva RNR da. Sph2(176–191) and Sph2(446–459): identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), naturally recognized by patients infected by pathogenic Leptospires [Internet]. Vaccines. 2023 ; 11( 2): 1-19.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11020359
Vancouver
Ataides LS’A, Maia F de M, Conte FP, Isaac L, Barbosa AS, Lima-Junior J da C, Avelar KES, Silva RNR da. Sph2(176–191) and Sph2(446–459): identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), naturally recognized by patients infected by pathogenic Leptospires [Internet]. Vaccines. 2023 ; 11( 2): 1-19.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11020359
Artigo de periodico
The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline (2023)
Minakawa, Marcia Michie ; Frazão, Paulo
Fonte: Vaccines. Unidade: FSP
Assuntos: VACINAÇÃO, COBERTURA DE SERVIÇOS PÚBLICOS DE SAÚDE, POLÍTICAS PÚBLICAS, POLÍTICA DE SAÚDE, PROGRAMAS NACIONAIS DE SAÚDE, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MINAKAWA, Marcia Michie e FRAZÃO, Paulo. The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline. Vaccines, v. 11, n. 7, p. art. 1189 [13], 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11071189. Acesso em: 25 set. 2024.
APA
Minakawa, M. M., & Frazão, P. (2023). The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline. Vaccines, 11( 7), art. 1189 [13]. doi:10.3390/vaccines11071189
NLM
Minakawa MM, Frazão P. The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline [Internet]. Vaccines. 2023 ;11( 7): art. 1189 [13].[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11071189
Vancouver
Minakawa MM, Frazão P. The Trajectory of Brazilian Immunization Program between 1980 and 2018: From the Virtuous Cycle to the Vaccine Coverage Decline [Internet]. Vaccines. 2023 ;11( 7): art. 1189 [13].[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11071189
Artigo de periodico
Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV (2023)
Nardy, Ariane ; Camargo, Camila Tussato Soares ; Oliveira, Yasmim Faustina Castro de ; Silva, Fernanda Cristina da; Almeida, Millena Soares de; Monteiro, Fernanda Rodrigues ; Silva, Brenda Rodrigues ; Amaral, Jônatas Bussador do ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Scagion, Guilherme Pereira ; Chalup, Vanessa Nascimento ; Candido, Érika Donizetti ; Aguiar, Andressa Simões ; Novo, Neil Ferreira ; Shio, Marina Tiemi ; França, Carolina Nunes ; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda
Fonte: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, POLIMORFISMO, CITOMEGALOVIRUS, IMUNOGLOBULINAS, SURTOS DE DOENÇAS, COVID-19, INTERFERONS, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDY, Ariane et al. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, v. 11, n. 2, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11020480. Acesso em: 25 set. 2024.
APA
Nardy, A., Camargo, C. T. S., Oliveira, Y. F. C. de, Silva, F. C. da, Almeida, M. S. de, Monteiro, F. R., et al. (2023). Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, 11( 2), 1-18. doi:10.3390/vaccines11020480
NLM
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11020480
Vancouver
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines11020480
Artigo de periodico
Vaccines against emerging and neglected infectious diseases: an overview (2022)
Vuitika, Larissa ; Syed, Wasim Aluísio Prates ; Silva, Jaqueline Dinis Queiros; Crema, Karin Paola ; Oliveira, Nelson Côrtes de ; Lira, Aline Aparecida de lima ; Lima, Julia Beatriz Menuci ; Câmara, Niels Olsen Saraiva ; Schimke, Lena Friederike ; Marques, Otavio Cabral ; Sadraeian, Mohammad ; Chaves, Lorena C. S. ; Miranda, Gustavo Cabral de
Fonte: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Assuntos: IMUNOLOGIA, VACINAS, DOENÇAS INFECCIOSAS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUITIKA, Larissa et al. Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, v. 10, n. 9, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091385. Acesso em: 25 set. 2024.
APA
Vuitika, L., Syed, W. A. P., Silva, J. D. Q., Crema, K. P., Oliveira, N. C. de, Lira, A. A. de lima, et al. (2022). Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, 10( 9), 1-11. doi:10.3390/vaccines10091385
NLM
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10091385
Vancouver
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10091385
Artigo de periodico
Brazilian adults’ attitudes and practices regarding the mandatory COVID-19 vaccination and their hesitancy towards childhood vaccination (2022)
Martinez, Edson Zangiacomi ; Zucoloto, Miriane Lucindo; Ramos, Vânia Pinheiro; Dutra, Carla Daiane Costa; Jesus, Giselle Juliana de; Esteves, Arinete Véras Fontes; Abreu, Isabella Schroeder; Mombelli, Monica Augusta ; Reis, Roberta Alvarenga; Campoamor, Marília Marcondes ; Silva, Wanderson Roberto da; Santos, Claudia Benedita dos
Fonte: Vaccines. Unidades: FMRP, EERP, FSP
Assuntos: COVID-19, ATITUDES FRENTE À DOENÇA, VACINAÇÃO, SAÚDE PÚBLICA, CRIANÇAS, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Edson Zangiacomi et al. Brazilian adults’ attitudes and practices regarding the mandatory COVID-19 vaccination and their hesitancy towards childhood vaccination. Vaccines, v. 10, n. 11, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10111853. Acesso em: 25 set. 2024.
APA
Martinez, E. Z., Zucoloto, M. L., Ramos, V. P., Dutra, C. D. C., Jesus, G. J. de, Esteves, A. V. F., et al. (2022). Brazilian adults’ attitudes and practices regarding the mandatory COVID-19 vaccination and their hesitancy towards childhood vaccination. Vaccines, 10( 11), 1-16. doi:10.3390/vaccines10111853
NLM
Martinez EZ, Zucoloto ML, Ramos VP, Dutra CDC, Jesus GJ de, Esteves AVF, Abreu IS, Mombelli MA, Reis RA, Campoamor MM, Silva WR da, Santos CB dos. Brazilian adults’ attitudes and practices regarding the mandatory COVID-19 vaccination and their hesitancy towards childhood vaccination [Internet]. Vaccines. 2022 ; 10( 11): 1-16.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10111853
Vancouver
Martinez EZ, Zucoloto ML, Ramos VP, Dutra CDC, Jesus GJ de, Esteves AVF, Abreu IS, Mombelli MA, Reis RA, Campoamor MM, Silva WR da, Santos CB dos. Brazilian adults’ attitudes and practices regarding the mandatory COVID-19 vaccination and their hesitancy towards childhood vaccination [Internet]. Vaccines. 2022 ; 10( 11): 1-16.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10111853
Artigo de periodico
Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors (2022)
Buss, Lewis Fletcher ; Prete Junior, Carlos Augusto ; Whittaker, Charles ; Salomon, Tassila ; Oikawa, Márcio Katsumi ; Pereira, Rafael H. M. ; Moura, Isabel C. G.; Delerino, Lucas; Franca, Rafael Freitas de Oliveira ; Miyajima, Fabio; Mendrone Júnior, Alfredo ; Almeida Neto, César de ; Salles, Nanci A. ; Ferreira, Suzete Cleuza ; Fladzinski, Karine A.; Souza, Luana Mendes de; Schier, Luciane K.; Inoue, Patricia M.; Kabregas, Lilyane A. Xabregas; Crispim, Myuki A. E. ; Fraiji, Nelson A ; Calos, Luciana M. B.; Pessoa, Veridiana Pessoa; Ribeiro, Maisa A.; Souza, Rosenvaldo E. de; Cavalcante, Anna F.; Valença, Maria I. B.; Silva, Maria V. da; Lopes, Esther; Filho, Luiz A.; Mateos, Sheila de Oliveira Garcia; Nunes, Gabrielle T.; Schlesinger, David; Silva, Sônia Mara Nunes da; Silva-Junior, Alexander L. ,; Castro, Marcia C. ; Nascimento, Vítor Heloiz ; Dye, Christopher ; Busch, Michael P; Faria, Nuno Rodrigues ; Sabino, Ester Cerdeira
Fonte: Vaccines. Unidades: EP, IMT
Assuntos: COVID-19, IMUNIDADE, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUSS, Lewis Fletcher et al. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors. Vaccines, v. 10, n. 9, p. 1437-1447, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091437. Acesso em: 25 set. 2024.
APA
Buss, L. F., Prete Junior, C. A., Whittaker, C., Salomon, T., Oikawa, M. K., Pereira, R. H. M., et al. (2022). Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors. Vaccines, 10( 9), 1437-1447. doi:10.3390/vaccines10091437
NLM
Buss LF, Prete Junior CA, Whittaker C, Salomon T, Oikawa MK, Pereira RHM, Moura ICG, Delerino L, Franca RF de O, Miyajima F, Mendrone Júnior A, Almeida Neto C de, Salles NA, Ferreira SC, Fladzinski KA, Souza LM de, Schier LK, Inoue PM, Kabregas LAX, Crispim MAE, Fraiji NA, Calos LMB, Pessoa VP, Ribeiro MA, Souza RE de, Cavalcante AF, Valença MIB, Silva MV da, Lopes E, Filho LA, Mateos S de OG, Nunes GT, Schlesinger D, Silva SMN da, Silva-Junior AL, Castro MC, Nascimento VH, Dye C, Busch MP, Faria NR, Sabino EC. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors [Internet]. Vaccines. 2022 ;10( 9): 1437-1447.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10091437
Vancouver
Buss LF, Prete Junior CA, Whittaker C, Salomon T, Oikawa MK, Pereira RHM, Moura ICG, Delerino L, Franca RF de O, Miyajima F, Mendrone Júnior A, Almeida Neto C de, Salles NA, Ferreira SC, Fladzinski KA, Souza LM de, Schier LK, Inoue PM, Kabregas LAX, Crispim MAE, Fraiji NA, Calos LMB, Pessoa VP, Ribeiro MA, Souza RE de, Cavalcante AF, Valença MIB, Silva MV da, Lopes E, Filho LA, Mateos S de OG, Nunes GT, Schlesinger D, Silva SMN da, Silva-Junior AL, Castro MC, Nascimento VH, Dye C, Busch MP, Faria NR, Sabino EC. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors [Internet]. Vaccines. 2022 ;10( 9): 1437-1447.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10091437
Artigo de periodico
LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression (2022)
Teixeira, Franciane Mouradian Emidio ; Oliveira, Luana de Mendonça ; Pietrobon, Anna Julia ; Salles, Érika Machado ; Lima, Maria Regina D'Império ; Viana, Isabelle Freire Tabosa; Lins, Roberto Dias ; Rigato, Paula Ordonhez ; Marques, Ernesto Torres de Azevedo ; Duarte, Alberto José da Silva; Sato, Maria Notomi
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, RECÉM-NASCIDO, VACINAS VIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, IMUNOGENICIDADE DA VACINA, HIV, DNA VIRAL, LISOSSOMOS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Franciane Mouradian Emidio et al. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression. Vaccines, v. 10, n. 8, p. 14 , 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10081246. Acesso em: 25 set. 2024.
APA
Teixeira, F. M. E., Oliveira, L. de M., Pietrobon, A. J., Salles, É. M., Lima, M. R. D. 'I., Viana, I. F. T., et al. (2022). LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression. Vaccines, 10( 8), 14 . doi:10.3390/vaccines10081246
NLM
Teixeira FME, Oliveira L de M, Pietrobon AJ, Salles ÉM, Lima MRD'I, Viana IFT, Lins RD, Rigato PO, Marques ET de A, Duarte AJ da S, Sato MN. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression [Internet]. Vaccines. 2022 ; 10( 8): 14 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10081246
Vancouver
Teixeira FME, Oliveira L de M, Pietrobon AJ, Salles ÉM, Lima MRD'I, Viana IFT, Lins RD, Rigato PO, Marques ET de A, Duarte AJ da S, Sato MN. LAMP-1 chimeric to HIV-1 p55Gag in the immunization of neonate mice induces an early germinal center formation and AID expression [Internet]. Vaccines. 2022 ; 10( 8): 14 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10081246
Artigo de periodico
COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study (2022)
Paganoti, Cristiane de Freitas; Costa, Rafaela Alkmin da; Papageorghiou, Aris T.; Costa, Fabrício da Silva; Quintana, Silvana Maria; Godoi, Luciana Graziela de; Monroy, Nátaly Adriana Jiménez; Rodrigues, Agatha Sacramento; Francisco, Rossana Pulccinelli Vieira
Fonte: Vaccines. Unidades: FM, FMRP
Assuntos: COVID-19, VACINAS, GRAVIDEZ, MORTALIDADE MATERNA, INTUBAÇÃO, UNIDADES DE TERAPIA INTENSIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAGANOTI, Cristiane de Freitas et al. COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study. Vaccines, v. 10, n. 5, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10050749. Acesso em: 25 set. 2024.
APA
Paganoti, C. de F., Costa, R. A. da, Papageorghiou, A. T., Costa, F. da S., Quintana, S. M., Godoi, L. G. de, et al. (2022). COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study. Vaccines, 10( 5), 1-10. doi:10.3390/vaccines10050749
NLM
Paganoti C de F, Costa RA da, Papageorghiou AT, Costa F da S, Quintana SM, Godoi LG de, Monroy NAJ, Rodrigues AS, Francisco RPV. COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study [Internet]. Vaccines. 2022 ; 10( 5): 1-10.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10050749
Vancouver
Paganoti C de F, Costa RA da, Papageorghiou AT, Costa F da S, Quintana SM, Godoi LG de, Monroy NAJ, Rodrigues AS, Francisco RPV. COVID-19 vaccines confer protection in hospitalized pregnant and postpartum women with severe COVID-19: a retrospective cohort study [Internet]. Vaccines. 2022 ; 10( 5): 1-10.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10050749
Artigo de periodico
Adjuvant Curdlan contributes to immunization against Cryptococcus gattii infection in a mouse strain-specific manner (2022)
Oliveira-Brito, Patrícia Kellen Martins ; Campos, Gabriela Yamazaki de; Guimarães, Júlia Garcia; Costa, Letícia Serafim da ; Moura, Edanielle Silva de; Lazo-Chica, Javier Emílio; Roque-Barreira, Maria Cristina ; Silva, Thiago Aparecido da
Fonte: Vaccines. Unidades: FMRP, ICB
Assuntos: CRYPTOCOCCUS, IMUNOTERAPIA, PEPTÍDEOS, ANTIFÚNGICOS, CRIPTOCOCOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-BRITO, Patrícia Kellen Martins et al. Adjuvant Curdlan contributes to immunization against Cryptococcus gattii infection in a mouse strain-specific manner. Vaccines, v. 10, n. 4, p. 1-26, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10040620. Acesso em: 25 set. 2024.
APA
Oliveira-Brito, P. K. M., Campos, G. Y. de, Guimarães, J. G., Costa, L. S. da, Moura, E. S. de, Lazo-Chica, J. E., et al. (2022). Adjuvant Curdlan contributes to immunization against Cryptococcus gattii infection in a mouse strain-specific manner. Vaccines, 10( 4), 1-26. doi:10.3390/vaccines10040620
NLM
Oliveira-Brito PKM, Campos GY de, Guimarães JG, Costa LS da, Moura ES de, Lazo-Chica JE, Roque-Barreira MC, Silva TA da. Adjuvant Curdlan contributes to immunization against Cryptococcus gattii infection in a mouse strain-specific manner [Internet]. Vaccines. 2022 ; 10( 4): 1-26.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10040620
Vancouver
Oliveira-Brito PKM, Campos GY de, Guimarães JG, Costa LS da, Moura ES de, Lazo-Chica JE, Roque-Barreira MC, Silva TA da. Adjuvant Curdlan contributes to immunization against Cryptococcus gattii infection in a mouse strain-specific manner [Internet]. Vaccines. 2022 ; 10( 4): 1-26.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines10040620
Artigo de periodico
Human transcriptomic response to the VSV-vectored ebola vaccine (2021)
Santoro, Francesco ; Donato, Alessia; Lucchesi, Simone ; Sorgi, Sara ; Gerlini, Alice; Haks, Marielle C ; Ottenhoff, Tom H. M ; Dias, Patricia Gonzalez ; Nakaya, Helder Takashi Imoto ; Huttner, Angela; Siegrist, Claire-Anne; Medaglini, Donata; Pozzi, Gianni
Fonte: Vaccines. Unidade: FCF
Assuntos: VÍRUS EBOLA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTORO, Francesco et al. Human transcriptomic response to the VSV-vectored ebola vaccine. Vaccines, v. 9, p. 1-15 art. 67, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9020067. Acesso em: 25 set. 2024.
APA
Santoro, F., Donato, A., Lucchesi, S., Sorgi, S., Gerlini, A., Haks, M. C., et al. (2021). Human transcriptomic response to the VSV-vectored ebola vaccine. Vaccines, 9, 1-15 art. 67. doi:10.3390/vaccines9020067
NLM
Santoro F, Donato A, Lucchesi S, Sorgi S, Gerlini A, Haks MC, Ottenhoff THM, Dias PG, Nakaya HTI, Huttner A, Siegrist C-A, Medaglini D, Pozzi G. Human transcriptomic response to the VSV-vectored ebola vaccine [Internet]. Vaccines. 2021 ; 9 1-15 art. 67.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020067
Vancouver
Santoro F, Donato A, Lucchesi S, Sorgi S, Gerlini A, Haks MC, Ottenhoff THM, Dias PG, Nakaya HTI, Huttner A, Siegrist C-A, Medaglini D, Pozzi G. Human transcriptomic response to the VSV-vectored ebola vaccine [Internet]. Vaccines. 2021 ; 9 1-15 art. 67.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020067
Artigo de periodico
VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants (2021)
Syed, Wasim Aluisio Prates ; Chaves, Lorena C. S. ; Crema, Karin Paola; Vuitika, Larissa; Lira, Aline ; Cortês, Nelson de Angelis ; Kersten, Victor; Guimarães, Francisco Eduardo Gontijo ; Sadraeian, Mohammad ; Silva, Fernando Luís Barroso da ; Cabral-Marques, Otávio ; Barbuto, José Alexandre Marzagão ; Russo, Momtchilo ; Câmara, Niels Olsen Saraiva ; Miranda, Gustavo Cabral de
Fonte: Vaccines. Unidades: IFSC, FCFRP, ICB, BIOTECNOLOGIA
Assuntos: COVID-19, CORONAVIRUS, VACINAS VIRAIS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SYED, Wasim Aluisio Prates et al. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, v. 9, n. 12, p. 1409-1-1409-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9121409. Acesso em: 25 set. 2024.
APA
Syed, W. A. P., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A., Cortês, N. de A., et al. (2021). VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, 9( 12), 1409-1-1409-17. doi:10.3390/vaccines9121409
NLM
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9121409
Vancouver
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9121409
Artigo de periodico
Elderly subjects supplemented with L-glutamine shows an improvement of mucosal immunity in the upper airways in response to influenza virus vaccination (2021)
Paixão, Vitória ; Almeida, Ewin Barbosa ; Amaral, Jonatas Bussador ; Roseira, Tamaris ; Monteiro, Fernanda R.; Foster, Roberta; Sperandio, Adriane; Rossi, Marcelo; Amirato, Gislene R.; Santos, Carlos A. F.; Pires, Renier S.; Oliveira, Fabyano Bruno Leal de ; Durigon, Edison Luiz ; Oliveira, Danielle Bruno Leal de ; Vieira, Rodolfo P. ; Vaisberg, Mauro ; Santos, Juliana de Melo Batista dos ; Bachi, André L. L.
Fonte: Vaccines. Unidade: ICB
Assuntos: MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, GLUTAMINA, ANTICORPOS, INFLUENZA, CITOCINAS, IDOSOS, VACINAÇÃO, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAIXÃO, Vitória et al. Elderly subjects supplemented with L-glutamine shows an improvement of mucosal immunity in the upper airways in response to influenza virus vaccination. Vaccines, v. 9, n. 2, p. 16 , 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9020107. Acesso em: 25 set. 2024.
APA
Paixão, V., Almeida, E. B., Amaral, J. B., Roseira, T., Monteiro, F. R., Foster, R., et al. (2021). Elderly subjects supplemented with L-glutamine shows an improvement of mucosal immunity in the upper airways in response to influenza virus vaccination. Vaccines, 9( 2), 16 . doi:10.3390/vaccines9020107
NLM
Paixão V, Almeida EB, Amaral JB, Roseira T, Monteiro FR, Foster R, Sperandio A, Rossi M, Amirato GR, Santos CAF, Pires RS, Oliveira FBL de, Durigon EL, Oliveira DBL de, Vieira RP, Vaisberg M, Santos J de MB dos, Bachi ALL. Elderly subjects supplemented with L-glutamine shows an improvement of mucosal immunity in the upper airways in response to influenza virus vaccination [Internet]. Vaccines. 2021 ; 9( 2): 16 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020107
Vancouver
Paixão V, Almeida EB, Amaral JB, Roseira T, Monteiro FR, Foster R, Sperandio A, Rossi M, Amirato GR, Santos CAF, Pires RS, Oliveira FBL de, Durigon EL, Oliveira DBL de, Vieira RP, Vaisberg M, Santos J de MB dos, Bachi ALL. Elderly subjects supplemented with L-glutamine shows an improvement of mucosal immunity in the upper airways in response to influenza virus vaccination [Internet]. Vaccines. 2021 ; 9( 2): 16 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020107
Artigo de periodico
Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine (2021)
Santos, Kamila Reis ; Souza, Fernando Nogueira de ; Ramos-Sanchez, Eduardo Milton ; Batista, Camila Freitas ; Reis, Luiza Campos ; Fotoran, Wesley F. ; Heinemann, Marcos Bryan ; Goto, Hiro ; Gidlund, Magnus Ake ; Cunha, Adriano F ; Faria, Angélica Rosa; Andrade, Hélida Monteiro de; Lage, Andrey Pereira ; Cerqueira, Monica Maria Oliveira Pinho; Della Libera, Alice Maria Melville Paiva
Fonte: Vaccines. Unidades: FMVZ, FM, ICB
Assuntos: VACINAS, STAPHYLOCOCCUS, MASTITE ANIMAL, BOVINOS LEITEIROS, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Kamila Reis et al. Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine. Vaccines, v. 9, n. 8, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9080899. Acesso em: 25 set. 2024.
APA
Santos, K. R., Souza, F. N. de, Ramos-Sanchez, E. M., Batista, C. F., Reis, L. C., Fotoran, W. F., et al. (2021). Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine. Vaccines, 9( 8), 1-16. doi:10.3390/vaccines9080899
NLM
Santos KR, Souza FN de, Ramos-Sanchez EM, Batista CF, Reis LC, Fotoran WF, Heinemann MB, Goto H, Gidlund MA, Cunha AF, Faria AR, Andrade HM de, Lage AP, Cerqueira MMOP, Della Libera AMMP. Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine [Internet]. Vaccines. 2021 ; 9( 8): 1-16.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9080899
Vancouver
Santos KR, Souza FN de, Ramos-Sanchez EM, Batista CF, Reis LC, Fotoran WF, Heinemann MB, Goto H, Gidlund MA, Cunha AF, Faria AR, Andrade HM de, Lage AP, Cerqueira MMOP, Della Libera AMMP. Staphylococcus aureus protection-related type 3 cell-mediated immune response elicited by recombinant proteins and GM-CSF DNA vaccine [Internet]. Vaccines. 2021 ; 9( 8): 1-16.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9080899
Artigo de periodico
Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach (2021)
Sousa, Álvaro Francisco Lopes de; Teixeira, Jules Ramon Brito; Lua, Iracema; Souza, Fernanda de Oliveira; Ferreira, Andrêa Jacqueline Fortes; Schneider, Guilherme ; Carvalho, Herica Emilia Félix de ; Oliveira, Layze Braz de ; Lima, Shirley Verônica Melo Almeida; Sousa, Anderson Reis de; Araújo, Telma Maria Evangelista de; Camargo, Emerson Lucas Silva; Mendes, Isabel Amélia Costa ; Ventura, Carla Aparecida Arena ; Oliveira, Rodrigo Mota de
Fonte: Vaccines. Unidade: EERP
Assuntos: VACINAS, COVID-19, SAÚDE MUNDIAL, DESINFORMAÇÃO, PANDEMIAS, NEGACIONISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Álvaro Francisco Lopes de et al. Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach. Vaccines, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9101167. Acesso em: 25 set. 2024.
APA
Sousa, Á. F. L. de, Teixeira, J. R. B., Lua, I., Souza, F. de O., Ferreira, A. J. F., Schneider, G., et al. (2021). Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach. Vaccines. doi:10.3390/vaccines9101167
NLM
Sousa ÁFL de, Teixeira JRB, Lua I, Souza F de O, Ferreira AJF, Schneider G, Carvalho HEF de, Oliveira LB de, Lima SVMA, Sousa AR de, Araújo TME de, Camargo ELS, Mendes IAC, Ventura CAA, Oliveira RM de. Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach [Internet]. Vaccines. 2021 ;[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9101167
Vancouver
Sousa ÁFL de, Teixeira JRB, Lua I, Souza F de O, Ferreira AJF, Schneider G, Carvalho HEF de, Oliveira LB de, Lima SVMA, Sousa AR de, Araújo TME de, Camargo ELS, Mendes IAC, Ventura CAA, Oliveira RM de. Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach [Internet]. Vaccines. 2021 ;[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9101167
Artigo de periodico
Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens (2021)
Ferreira, Helena Lage ; Miller, Patti J.; Suarez, David L.
Fonte: Vaccines. Unidade: FZEA
Assuntos: VACINAS, AVES, IMUNIDADE, DOENÇA DE NEWCASTLE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Helena Lage e MILLER, Patti J. e SUAREZ, David L. Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens. Vaccines, v. 9, n. 2, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9020182. Acesso em: 25 set. 2024.
APA
Ferreira, H. L., Miller, P. J., & Suarez, D. L. (2021). Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens. Vaccines, 9( 2), 1-18. doi:10.3390/vaccines9020182
NLM
Ferreira HL, Miller PJ, Suarez DL. Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens [Internet]. Vaccines. 2021 ; 9( 2): 1-18.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020182
Vancouver
Ferreira HL, Miller PJ, Suarez DL. Protection against different genotypes of Newcastle disease viruses (NDV) afforded by an adenovirus-vectored fusion protein and live NDV vaccines in chickens [Internet]. Vaccines. 2021 ; 9( 2): 1-18.[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines9020182
Artigo de periodico
Combined exercise training and l-Glutamine supplementation enhances both humoral and cellular immune responses after influenza virus vaccination in elderly subjects (2020)
Monteiro, Fernanda R. ; Roseira, Tamaris ; Amaral, Jonatas Bussador ; Paixão, Vitória ; Almeida, Ewin Bussador ; Foster, Roberta ; Sperandio, Adriane ; Rossi, Marcelo; Amirato, Gislene R.; Apostólico, Juliana de Souza ; Santos, Carlos A. F.; Felismino, Eduardo Santos ; Oliveira, Fabyano Bruno Leal de ; Thomazelli, Luciano Matsumiya ; Durigon, Edison Luiz ; Oliveira, Danielle Bruna Leal de ; Vieira, Rodolfo de Paula ; Santos, Juliana M. B.; Bachi, André L. L.
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: MICROBIOLOGIA, GLUTAMINA, TREINAMENTO FÍSICO, IMUNOLOGIA CELULAR, VACINAÇÃO, VACINAS VIRAIS, INFLUENZA, IDOSOS, AMINOÁCIDOS, LINFÓCITOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Fernanda R. et al. Combined exercise training and l-Glutamine supplementation enhances both humoral and cellular immune responses after influenza virus vaccination in elderly subjects. Vaccines, v. 8, n. 4, p. 15 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040685. Acesso em: 25 set. 2024.
APA
Monteiro, F. R., Roseira, T., Amaral, J. B., Paixão, V., Almeida, E. B., Foster, R., et al. (2020). Combined exercise training and l-Glutamine supplementation enhances both humoral and cellular immune responses after influenza virus vaccination in elderly subjects. Vaccines, 8( 4), 15 . doi:10.3390/vaccines8040685
NLM
Monteiro FR, Roseira T, Amaral JB, Paixão V, Almeida EB, Foster R, Sperandio A, Rossi M, Amirato GR, Apostólico J de S, Santos CAF, Felismino ES, Oliveira FBL de, Thomazelli LM, Durigon EL, Oliveira DBL de, Vieira R de P, Santos JMB, Bachi ALL. Combined exercise training and l-Glutamine supplementation enhances both humoral and cellular immune responses after influenza virus vaccination in elderly subjects [Internet]. Vaccines. 2020 ; 8( 4): 15 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines8040685
Vancouver
Monteiro FR, Roseira T, Amaral JB, Paixão V, Almeida EB, Foster R, Sperandio A, Rossi M, Amirato GR, Apostólico J de S, Santos CAF, Felismino ES, Oliveira FBL de, Thomazelli LM, Durigon EL, Oliveira DBL de, Vieira R de P, Santos JMB, Bachi ALL. Combined exercise training and l-Glutamine supplementation enhances both humoral and cellular immune responses after influenza virus vaccination in elderly subjects [Internet]. Vaccines. 2020 ; 8( 4): 15 .[citado 2024 set. 25 ] Available from: https://doi.org/10.3390/vaccines8040685

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos